JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The relationship in gating effects between short-latency and long-latency somatosensory-evoked potentials.

Neuroreport 2011 December 22
We investigated the relationship between short-latency and long-latency somatosensory-evoked potentials (SEPs) relating to voluntary movement. In general, the amplitudes of short-latency components in SEPs are attenuated during movement, whereas those of long-latency are enhanced, and this phenomenon is termed 'gating effects'. This study aimed to examine the relationship of changes in amplitude between short-latency and long-latency SEPs. SEPs were recorded from 11 participants at Fz, Cz, Pz, and C4' by stimulating the left median nerve. Two tasks were conducted; Control and Movement. In Control, the participant was asked to relax with no specific task. In Movement, the participant was encouraged to continue a rapid drumming motion of all fingers of the left hand at a self-paced rate. The amplitudes of short-latency SEPs, the P25 at C4' and N30 at Fz, were significantly smaller in the Movement than Control condition. By contrast, the amplitudes of long-latency SEPs, the N140 at Fz, Cz, and Pz were significantly larger in Movement than Control condition. Moreover, a significant positive correlation was observed in the rate of amplitude change between the frontal N30 and vertex N140, indicating that for the participants with a frontal N30 of smaller amplitude during Movement, the amplitude of the vertex N140 was smaller. We inferred that the neural activities in movement-related cortices affected the sources for the frontal N30 and vertex N140 in the same neuronal network simultaneously.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app